ADUS vs BIO · P/E 17, rev $741.0M vs rev $651.0M
Addus HomeCare Corporation (ADUS) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Addus HomeCare Corporation (ADUS) is a medical care facilities company listed on NASDAQ.
BIO (BIO) common stock.
Latest reported ADUS revenue for 2026-06-30 was $741.0M. Net income was $52.7M. ADUS currently screens at market cap $1.75B and trailing P/E 17.3.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
ADUS currently screens at market cap $1.75B and trailing P/E 17.3. BIO currently screens at market cap $0.
Not investment advice. Open the ADUS and BIO stock pages for the full models.
Not investment advice.